ArticleCNS drugs2025

The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's Disease.

Yigal Paul Goldberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.